Cargando…

Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness

Systemic inflammation and duration of immobilization are strong independent risk factors for the development of intensive care unit-acquired weakness (ICUAW). Activation of the pro-inflammatory transcription factor nuclear factor-κB (NF-κB) results in muscle wasting during disuse-induced skeletal mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meduri, Gianfranco Umberto, Schwingshackl, Andreas, Hermans, Greet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969316/ https://www.ncbi.nlm.nih.gov/pubmed/27532030 http://dx.doi.org/10.3389/fped.2016.00069

Ejemplares similares

Rationale for Prolonged Glucocorticoid Use in Pediatric ARDS: What the Adults Can Teach Us
por: Schwingshackl, Andreas, et al.
Publicado: (2016)

Plasma Biomarker Analysis in Pediatric ARDS: Generating Future Framework from a Pilot Randomized Control Trial of Methylprednisolone: A Framework for Identifying Plasma Biomarkers Related to Clinical Outcomes in Pediatric ARDS
por: Kimura, Dai, et al.
Publicado: (2016)

Clinical review: intensive care unit acquired weakness
por: Hermans, Greet, et al.
Publicado: (2015)

Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2020)

Intensive care unit acquired muscle weakness in COVID-19 patients
por: Van Aerde, Nathalie, et al.
Publicado: (2020)

Editorial: ARDS: Reaching for the Horizon
por: McGuire, John K., et al.
Publicado: (2017)

Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment
por: Umberto Meduri, Gianfranco, et al.
Publicado: (2011)

Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2018)

Neurophysiological Assessment of Prolonged Recovery From Neuromuscular Blockade in the Neonatal Intensive Care Unit
por: Soffer, Omri David, et al.
Publicado: (2020)

The Prevalence and Outcome of Intensive Care Unit Acquired Weakness (ICUAW)
por: Panahi, Ali, et al.
Publicado: (2020)

Facial nerve neurographies in intensive care unit-acquired weakness
por: Lochter, Maximilian, et al.
Publicado: (2023)

ICU-acquired weakness
por: Vanhorebeek, Ilse, et al.
Publicado: (2020)

General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2020)

The Fallacy of Chasing after Work-Life Balance
por: Schwingshackl, Andreas
Publicado: (2014)

Intensive Care Unit Acquired Weakness Associated With Acute Severe Asthma
por: Borré-Naranjo, Diana, et al.
Publicado: (2022)

Molecular Mechanisms Underlying Intensive Care Unit-Acquired Weakness and Sarcopenia
por: Kanova, Marcela, et al.
Publicado: (2022)

Diagnostic workup for ARDS patients
por: Papazian, Laurent, et al.
Publicado: (2016)

Prolonged corticosteroid treatment in acute respiratory distress syndrome: impact on mortality and ventilator-free days
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2018)

Glycemic variability as a risk factor of intensive care unit-acquired weakness
por: Mörgeli, R, et al.
Publicado: (2015)

Intensive care unit acquired weakness in children: Critical illness polyneuropathy and myopathy
por: Kukreti, Vinay, et al.
Publicado: (2014)

Intensive care unit–acquired weakness: unanswered questions and targets for future research
por: Piva, Simone, et al.
Publicado: (2019)

Intensive Care Unit-Acquired Weakness: Not Just Another Muscle Atrophying Condition
por: Lad, Heta, et al.
Publicado: (2020)

Intensive Care Unit-acquired Weakness: A Frequent but Under-recognized Threat
por: Sapra, Harsh
Publicado: (2021)

Healthcare-Associated Viral Respiratory Infections in a Pediatric Intensive Care Unit and Cardiovascular Intensive Care Unit
por: Feldman, Kelly, et al.
Publicado: (2021)

Biomarkers in Pediatric ARDS: Future Directions
por: Orwoll, Benjamin E., et al.
Publicado: (2016)

Glycemic Variability: An Independent Predictor of Mortality and the Impact of Age in Pediatric Intensive Care Unit
por: Du, Yuhui, et al.
Publicado: (2020)

Impact of COVID-19 on Respiratory Admissions in a Tertiary Pediatric Intensive Care Unit
por: Ambati, Shashikanth, et al.
Publicado: (2022)

Risk prediction models for intensive care unit-acquired weakness in intensive care unit patients: A systematic review
por: Zhang, Wei, et al.
Publicado: (2021)

Weakness acquired in the intensive care unit. Incidence, risk factors and their association with inspiratory weakness. Observational cohort study
por: Ballve, Ladislao Pablo Diaz, et al.
Publicado: (2017)

Editorial: Work–Life Balance: Essential or Ephemeral?
por: Schwingshackl, Andreas, et al.
Publicado: (2017)

Pantoea Infections in the Neonatal Intensive Care Unit
por: Mani, Srinivasan, et al.
Publicado: (2021)

Point-of-Care Ultrasound in the Pediatric Intensive Care Unit
por: Burton, Luke, et al.
Publicado: (2022)

The Impact of a Sibling's Death in Intensive Care Unit: Are We Doing Enough to Help Them?
por: Sombans, Shaheen, et al.
Publicado: (2018)

The SARS-CoV-2 Pandemic Impacts the Management of Swiss Pediatric Intensive Care Units
por: Soomann, Maarja, et al.
Publicado: (2022)

Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS
por: Deliloglu, Burak, et al.
Publicado: (2020)

The Clinical Characteristics of ARDS in Children With Hematological Neoplasms
por: Zhang, Qiao, et al.
Publicado: (2021)

Skeletal Muscle Index at Intensive Care Unit Admission Is a Predictor of Intensive Care Unit-Acquired Weakness in Patients With Sepsis
por: Mitobe, Yuta, et al.
Publicado: (2019)

Intensive care unit acquired muscle weakness: when should we consider rehabilitation?
por: Puthucheary, Zudin, et al.
Publicado: (2009)

The increasing need for biomarkers in intensive care unit-acquired weakness - are microRNAs the solution?
por: Lugg, Sebastian T, et al.
Publicado: (2015)

Intensive Care Unit Acquired Weakness Is Associated with Rapid Changes to Skeletal Muscle Proteostasis
por: Ozdemir, Mustafa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ja8un6p9jeke0orioeg24gst5h